MentionFox
Home › funding signals › Aqur Biosciences, Inc.
Form D · on the record

Aqur Biosciences — $1.50M Form D filing, September 2026

Aqur Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2026-09-18.

Aqur Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 18, 2026. The filing reports $1.50M sold. Its industry group is Pharmaceuticals. It names Michael Fole (Executive Officer), Jeffrey Wolin (Executive Officer, Director), James Leach (Executive Officer) (SEC Form D, September 18, 2026).

In its own words: “Revolutionizing cardiovascular health with breakthrough science.” (aqurbiosciences.com, checked October 31, 2026)

Aqur Biosciences, Inc. raised on Sep 18. 125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

2 more Pharmaceuticals raises in California within 90 days ↓

Selling to Aqur Biosciences, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.

Is this your company?

Key facts

Run the free check on Aqur Biosciences, Inc. →

Sell to companies like Aqur Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Aqur Biosciences, Inc.

New Form D on file · 2026-09-18 · the record

$1.50M
raise on the record
D
filing
7
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2026-09-18
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inNEVADA
BasedWESTLAKE VILLAGE, CALIFORNIA
CIK2094075
Accession0001640334-26-001574

Pitching, partnering or investing alongside them? See who really runs and owns Aqur Biosciences, Inc.

Watch Aqur Biosciences, Inc.: email me the next time it files something

Free to see. No signup.

Keep reading

More on the people and the money behind Aqur Biosciences, Inc., from the filings we hold.

Raised through the same sales agent

Roth Capital Partners, LLC received sales compensation on this raise and on 4 other raises we hold, nearest in date first:

More raises like this

Pharmaceuticals raises by companies based in California, filed within 90 days of this one, largest first.

What do you want to do with Aqur Biosciences, Inc.?

Get the full cited report on Aqur Biosciences, Inc.

What the filing shows about Aqur Biosciences, Inc.

  • 7 investors had already put money in when it filed.
  • The filing names 5 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Aqur Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Aqur Biosciences, Inc.'s address as 2829 Townsgate Road, Suite 100, Westlake Village, CA 91361.

What the filing says

  • Offered: $1,500,000. Sold: $1,500,000. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 7 had already invested. (filing)
  • Date of first sale: September 3, 2026. (filing)
  • Types of securities: Equity; Options, warrants or other rights to acquire another security; Securities to be acquired on exercise of an option, warrant or other right. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “Sale of Series B Convertible Preferred Stock and accompanying warrants in a private placement to accredited investors” (filing)
  • On sales commissions and finders' fees: the filing adds “Roth Capital Partners, LLC was paid a fixed fee of $125,000 for advisory services related to the offering, but will not receive any sales commissions, finders' fees or other fees contingent upon subscriptions.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Aqur Biosciences, Inc. See pricing

Is Aqur Biosciences, Inc. a real, registered company?

Aqur Biosciences, Inc. is a registered filer with the SEC (CIK 2094075) and has filed since 2026-09-18. 1 filing is on record, the latest on 2026-09-18.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Aqur Biosciences, Inc.?

Aqur Biosciences, Inc.'s Form D of 2026-09-18 names Michael Fole, Jeffrey Wolin, James Leach and 2 more as its officers, directors or promoters.

How much has Aqur Biosciences, Inc. raised?

Its new offerings report $1.50M sold across 1 offering, as its own filings state.

Pharmaceuticals · by week
This raise, $1.50M, filed week of Sep 14

Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $1.50M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Aqur Biosciences, Inc.?

What the filing shows about Aqur Biosciences, Inc.

  • 7 investors had already put money in when it filed.
  • The filing names 5 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Aqur Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Aqur Biosciences, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Aqur Biosciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-27 (aqurbiosciences.com).

RSS

Tools for this story

Each opens in a new tab, filled in for Aqur Biosciences, Inc.. With no account yet, you sign up free and land on the result.

On these lists: Pharmaceuticals raises in Los Angeles

On these startup lists

Biotech startups

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Aqur Biosciences, Inc.: Raised $1.50M, Form D filed 2026-09-18
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/aqur-biosciences-inc-form-d-001574
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Aqur Biosciences raised $1.50M — SEC Form D filing, September 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/aqur-biosciences-inc-form-d-001574